-- Clal Biotechnology Climbs Most in Week on Alzheimer’s Drug Trial
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-01-23T09:35:06Z
-- http://www.bloomberg.com/news/2012-01-23/clal-biotechnology-climbs-most-in-week-on-alzheimer-s-drug-trial.html
Clal Biotechnology Industries Ltd. (CBI) 
advanced the most in a week after a unit’s Phase IIb trial of an
Alzheimer’s drug showed intermediate “positive” results.  The  shares o f the investment company gained as much as 2.3
percent, the biggest intraday increase since Jan. 16, and were 1
percent higher at 21.10 shekels as of 11:24 a.m. in  Tel Aviv .  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  